
Bafna Pharmaceuticals Investor Relations Material
Latest events

Q4 24/25
26 May, 2025

Q3 2025
6 Feb, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Bafna Pharmaceuticals Limited
Access all reports
Bafna Pharmaceuticals Limited is a pharmaceutical company engaged in the development, manufacturing, and marketing of generic and branded pharmaceutical formulations. The company produces a range of dosage forms including tablets, capsules, and oral liquids across various therapeutic segments. It supplies its products to both domestic and international markets, with a focus on regulated and semi-regulated regions. Bafna Pharmaceuticals Limited also offers contract manufacturing services and maintains compliance with global quality standards. The company is headquartered in Chennai, India, and its shares are listed on the BSE.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
BAFNAPH
Country
🇮🇳 India